CIK 0001711754
- Non-accelerated filer
- Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 475205835
- Phone
- +1 858-964-3720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy CFO, Treasurer & Secretary bought 18,028 shares at $8.32 ($149,993)
- 4/A Open-market buy President and CEO bought 18,028 shares at $8.32 ($149,993)
- 4/A Open-market buy Chief Scientific Officer bought 14,423 shares at $8.32 ($119,999)
- 4/A Open-market buy Director bought 29,603 shares at $8.32 ($246,297)
- 4 Grant or award President and CEO acquired 18,028 shares (grant or award)
- 4 Grant or award CFO, Treasurer & Secretary acquired 18,028 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 14,423 shares (grant or award)
- 4 Grant or award Director acquired 29,603 shares (grant or award)
- 4 Open-market buy Director bought 7,000 shares at $6.95 ($48,650)
- 4 Planned sale Director sold 10,000 shares at $11.01 ($110,085)
- 4 Open-market buy CFO, Treasurer & Secretary bought 2,500 shares at $6.43 ($16,063)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 8 · 142 filings